PURPOSE: the purpose of this study was to identify age-related oocyte or embryo markers suitable for non-invasive analysis, as women over 38 years of age experience diminished pregnancy and ovulation rates. METHODS: we used real-time quantitative PCR to examine the gene expression profiles in cumulus cells acquired from older and younger age groups. We selected 11 genes involved in three functions that directly affect cellular aging: cell cycle control, apoptosis, and metabolism. RESULTS: CKB and PRDX2 were up-regulated in women older than 38 years, and the expression of these genes in cumulus cells was associated with embryo quality. In good-quality embryos, CKB expression was higher in the cumulus cells acquired from both older and younger age groups than in poor-quality embryos. CONCLUSIONS: these potential relationships among cumulus cell gene expression, oocyte quality, and age may expand our understanding of oogenesis and embryo development. CKB and PRDX2 may serve as biomarkers or therapeutic targets for the developmental potential of oocytes.
PURPOSE: the purpose of this study was to identify age-related oocyte or embryo markers suitable for non-invasive analysis, as women over 38 years of age experience diminished pregnancy and ovulation rates. METHODS: we used real-time quantitative PCR to examine the gene expression profiles in cumulus cells acquired from older and younger age groups. We selected 11 genes involved in three functions that directly affect cellular aging: cell cycle control, apoptosis, and metabolism. RESULTS:CKB and PRDX2 were up-regulated in women older than 38 years, and the expression of these genes in cumulus cells was associated with embryo quality. In good-quality embryos, CKB expression was higher in the cumulus cells acquired from both older and younger age groups than in poor-quality embryos. CONCLUSIONS: these potential relationships among cumulus cell gene expression, oocyte quality, and age may expand our understanding of oogenesis and embryo development. CKB and PRDX2 may serve as biomarkers or therapeutic targets for the developmental potential of oocytes.
Authors: Heather G Huddleston; Kwong-Kwok Wong; William R Welch; Ross S Berkowitz; Samuel C Mok Journal: Gynecol Oncol Date: 2005-01 Impact factor: 5.482
Authors: J P de Bruin; M Dorland; E R Spek; G Posthuma; M van Haaften; C W N Looman; E R te Velde Journal: Biol Reprod Date: 2003-10-15 Impact factor: 4.285
Authors: David Pei-Cheng Lin; Chun Chia Huang; Hui Mei Wu; Tzu Chun Cheng; Chung I Chen; Maw Sheng Lee Journal: Fertil Steril Date: 2004-01 Impact factor: 7.329
Authors: Guang-Jian Jiang; Ke Wang; De-Qiang Miao; Lei Guo; Yi Hou; Heide Schatten; Qing-Yuan Sun Journal: PLoS One Date: 2011-12-16 Impact factor: 3.240
Authors: Tamadir Al-Edani; Said Assou; Alice Ferrières; Sophie Bringer Deutsch; Anna Gala; Charles-Henri Lecellier; Ounissa Aït-Ahmed; Samir Hamamah Journal: Biomed Res Int Date: 2014-09-03 Impact factor: 3.411
Authors: Anna Maria Muccini; Nhi T Tran; Deborah L de Guingand; Mamatha Philip; Paul A Della Gatta; Robert Galinsky; Larry S Sherman; Meredith A Kelleher; Kirsten R Palmer; Mary J Berry; David W Walker; Rod J Snow; Stacey J Ellery Journal: Nutrients Date: 2021-02-02 Impact factor: 5.717
Authors: Sandra Wathlet; Tom Adriaenssens; Ingrid Segers; Greta Verheyen; Lisbet Van Landuyt; Wim Coucke; Paul Devroey; Johan Smitz Journal: PLoS One Date: 2013-04-03 Impact factor: 3.240